These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 11136882)

  • 21. Skeletal effects of systemic and topical corticosteroids.
    Vestergaard P
    Curr Drug Saf; 2008 Sep; 3(3):190-3. PubMed ID: 18691000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammatory bowel disease and the risk of fracture.
    van Staa TP; Cooper C; Brusse LS; Leufkens H; Javaid MK; Arden NK
    Gastroenterology; 2003 Dec; 125(6):1591-7. PubMed ID: 14724810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fracture risk associated with systemic and topical corticosteroids.
    Vestergaard P; Rejnmark L; Mosekilde L
    J Intern Med; 2005 Apr; 257(4):374-84. PubMed ID: 15788008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhaled corticosteroids and the risks of low-energy fractures in patients with chronic airway diseases: A propensity score matched study.
    Tsai CH; Liao LY; Lin CL; Chung WS
    Clin Respir J; 2018 May; 12(5):1830-1837. PubMed ID: 29148205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral and inhaled corticosteroids and adrenal insufficiency: a case-control study.
    Mortimer KJ; Tata LJ; Smith CJ; West J; Harrison TW; Tattersfield AE; Hubbard RB
    Thorax; 2006 May; 61(5):405-8. PubMed ID: 16517576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse effects of oral corticosteroids in relation to dose in patients with lung disease.
    Walsh LJ; Wong CA; Oborne J; Cooper S; Lewis SA; Pringle M; Hubbard R; Tattersfield AE
    Thorax; 2001 Apr; 56(4):279-84. PubMed ID: 11254818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Steroid-induced osteoporosis. Are your asthmatic patients at risk?
    Niewoehner CB; Niewoehner DE
    Postgrad Med; 1999 Mar; 105(3):79-83, 87-8, 91. PubMed ID: 10086035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.
    Richy F; Schacht E; Bruyere O; Ethgen O; Gourlay M; Reginster JY
    Calcif Tissue Int; 2005 Mar; 76(3):176-86. PubMed ID: 15692726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhaled corticosteroids and hip fracture: a population-based case-control study.
    Hubbard RB; Smith CJ; Smeeth L; Harrison TW; Tattersfield AE
    Am J Respir Crit Care Med; 2002 Dec; 166(12 Pt 1):1563-6. PubMed ID: 12406825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term fracture risk among children with asthma: a population-based study.
    Melton LJ; Patel A; Achenbach SJ; Oberg AL; Yunginger JW
    J Bone Miner Res; 2005 Apr; 20(4):564-70. PubMed ID: 15765174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [CBO guideline 'Osteoporosis' (second revision].
    Pols HA; Wittenberg J
    Ned Tijdschr Geneeskd; 2002 Jul; 146(29):1359-63. PubMed ID: 12162173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of the risk of fracture in patients with gastrointestinal disease.
    Arden NK; Cooper C
    Eur J Gastroenterol Hepatol; 2003 Aug; 15(8):865-8. PubMed ID: 12867795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of cataract among users of intranasal corticosteroids.
    Derby L; Maier WC
    J Allergy Clin Immunol; 2000 May; 105(5):912-6. PubMed ID: 10808171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study.
    Waljee AK; Rogers MA; Lin P; Singal AG; Stein JD; Marks RM; Ayanian JZ; Nallamothu BK
    BMJ; 2017 Apr; 357():j1415. PubMed ID: 28404617
    [No Abstract]   [Full Text] [Related]  

  • 35. The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results.
    Van Staa TP; Abenhaim L; Cooper C; Zhang B; Leufkens HG
    Pharmacoepidemiol Drug Saf; 2000 Sep; 9(5):359-66. PubMed ID: 19025840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.
    Chesnut CH; Skag A; Christiansen C; Recker R; Stakkestad JA; Hoiseth A; Felsenberg D; Huss H; Gilbride J; Schimmer RC; Delmas PD;
    J Bone Miner Res; 2004 Aug; 19(8):1241-9. PubMed ID: 15231010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Damage in systemic lupus erythematosus and its association with corticosteroids.
    Zonana-Nacach A; Barr SG; Magder LS; Petri M
    Arthritis Rheum; 2000 Aug; 43(8):1801-8. PubMed ID: 10943870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal study of short-term corticosteroid use by working-age adults with diabetes mellitus: Risks and mitigating factors.
    Rogers MAM; Lin P; Nallamothu BK; Kim C; Waljee AK
    J Diabetes; 2018 Jul; 10(7):546-555. PubMed ID: 29193668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy.
    Van Staa TP; Laan RF; Barton IP; Cohen S; Reid DM; Cooper C
    Arthritis Rheum; 2003 Nov; 48(11):3224-9. PubMed ID: 14613287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vertebral fractures in boys with Duchenne muscular dystrophy.
    Bothwell JE; Gordon KE; Dooley JM; MacSween J; Cummings EA; Salisbury S
    Clin Pediatr (Phila); 2003 May; 42(4):353-6. PubMed ID: 12800730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.